Skip to main content

Metabolic Syndrom

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ADEL
ADELKorea - Seoul
1 program
High intensity interval trainingN/A1 trial
Active Trials
NCT06509464Recruiting48Est. Jun 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
ADELHigh intensity interval training

Clinical Trials (1)

Total enrollment: 48 patients across 1 trials

NCT06509464ADELHigh intensity interval training

Response Of Metabolic Syndrome Severity Score To High Intenisty Interval Training In Women With Central Obesity.

Start: Dec 2024Est. completion: Jun 202548 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 48 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.